NTRA - Natera plunges on new short call from Hindenburg Research
Natera Inc. (NASDAQ:NTRA) dropped 15% in premarket trading after Hindenburg Research released a new short report on the prenatal testing company Hindenburg alleges that Natera's revenue growth has been "fueled by deceptive sales and billing practices." The short report notes the company is still "starkly unprofitable." Natera (NTRA) didn't immediately respond to Seeking Alpha email request for comment. Natera short interest is 6%. Last month, Natera reported Q4 GAAP EPS of -$1.48 missed by $0.18, revenue of $173M beat by $4.19M.
For further details see:
Natera plunges on new short call from Hindenburg Research